Arrowhead Research | ARWR - Pasivo Circulante

Precio De Mercado
73.91
Cambio Diario
-0.49 -0.66%
Mensual
21.62%
Anual
457.81%
Q2 Expectativa
72.33




Pasivo Circulante Cambio Fecha
Agios Pharmaceuticals USD 82.21M 7.45M 2025-12
Alnylam Pharmaceuticals USD 1.47B 89.13M 2025-12
Anika Therapeutics USD 21.91M 2.82M 2025-12
Arrowhead Research USD 347.42M 151.94M 2025-12
Heron Therapeutics USD 96.1M 6.39M 2025-12
Incyte USD 1.52B 176.44M 2025-12
Ionis Pharmaceuticals USD 783M 120.46M 2025-12
Ligand Pharmaceuticals USD 37.45M 6.91M 2025-12
Merck USD 28.63B 2.59B 2025-09
Moderna USD 1.99B 306M 2025-12
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Sarepta Therapeutics USD 1.1B 173.86M 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Vertex Pharmaceuticals USD 3.86B 614.1M 2025-12
Xencor USD 95.91M 9.42M 2025-12